InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,433.74
(
0.00%
)
US TECH 100
19,050.80
(
-0.09%
)
Dow Jones
38,647.10
(
0.00%
)
Brent Oil
82.89
(
1.11%
)
Bitcoin
67,069.98
(
0.47%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 124

Sunday, 04/29/2018 10:21:26 AM

Sunday, April 29, 2018 10:21:26 AM

Post# of 438
EYPT is the former pSivida

EYPT was after pSivida acquired Icon and entered into a financial agreement for debt and equity with EW Healthcare

PDUFA for Yutiq is 11/5/18. Yutiq is a treatment for noninfectious posterior uveitis

I would not hold Yutiq close to the PDUFA date. Ph3 results are questionable. Treatment group experienced increased IOP compared to sham. 12% experienced IOP of greater than 11.9 mm Hg while sham was only ~4%

There will be an earnings cc on 5/8/18.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up